open access

Vol 75, No 10 (2017)
Original articles
Published online: 2017-06-28
Submitted: 2017-03-07
Accepted: 2017-06-08
Get Citation

Fifteen-year mortality trends due to cardiovascular diseases in Poland using standard expected years of life lost, 2000–2014

Małgorzata Pikala, Irena Maniecka-Bryła
DOI: 10.5603/KP.a2017.0124
·
Kardiol Pol 2017;75(10):1033-1040.

open access

Vol 75, No 10 (2017)
Original articles
Published online: 2017-06-28
Submitted: 2017-03-07
Accepted: 2017-06-08

Abstract

Background: Measures presenting the number of years of lost life point out social and economic aspects of premature mortality.

Aim: The aim of the study was to determine trends and pace of changes in years of life lost, in inhabitants of Poland, in 2000–2014, due to cardiovascular diseases (CVD).

Methods: The study material was a database including 2,587,141 death certificates of Polish inhabitants who died of CVD in 2000–2014. We applied the standard expected years of life lost (SEYLL) indicators per living person (SEYLLp) and per death (SEYLLd) to calculate life years lost. We also estimated annual percentage changes (APC) and average annual percentage changes (AAPC) in the SEYLL indicators.

Results: In 2000 the SEYLLp index due to CVD was 860.3 years per 10,000 males and 586.9 years per 10,000 females. In 2000–2004 the indices were decreasing and the average annual rate was –0.8% in the male group and –1.2% in the female group. Eventually, in 2014 its values were 721.4 years per 10,000 males and 475.6 years per 10,000 females. The respondents were losing years of life due to ischaemic heart disease (IHD) most rapidly (AAPC = –3.3% in the male group and –3.2% in the female group) and due to cerebrovascular diseases (AAPC = –2.5% in the male group and AAPC = –3.3% in the female group). On the other hand, there was an increase in the number of years of life lost due to heart failure (HF) (AAPC = 5.7% in the male group and AAPC = 4.4% in the female group). In 2014 SEYLLp due to IHD were 207.3 per 10,000 males and 99.1 per 10,000 females, due to cerebrovascular diseases — 124.3 and 102.2, and due to HF — 155.3 and 104.9. Each male who died of CVD lost on average 19.1 years in the year 2000 and 17.0 years in the year 2014 (AAPC = –0.5%). Regarding women, SEYLLd values were 12.6 years in 2000 and 10.4 years in 2014 (AAPC = –1.4%). A decrease in the SEYLLd value was observed in all analysed causes of mortality, in both males and females.

Conclusions: Among CVDs, IHD and cerebrovascular diseases contribute to the highest number of years of life lost in inhabitants of Poland. The constant decline in the average number of years of life lost by each person who died of CVD might result from implementation of more effective prophylaxis and more effective treatment, which extend lifespan.

Abstract

Background: Measures presenting the number of years of lost life point out social and economic aspects of premature mortality.

Aim: The aim of the study was to determine trends and pace of changes in years of life lost, in inhabitants of Poland, in 2000–2014, due to cardiovascular diseases (CVD).

Methods: The study material was a database including 2,587,141 death certificates of Polish inhabitants who died of CVD in 2000–2014. We applied the standard expected years of life lost (SEYLL) indicators per living person (SEYLLp) and per death (SEYLLd) to calculate life years lost. We also estimated annual percentage changes (APC) and average annual percentage changes (AAPC) in the SEYLL indicators.

Results: In 2000 the SEYLLp index due to CVD was 860.3 years per 10,000 males and 586.9 years per 10,000 females. In 2000–2004 the indices were decreasing and the average annual rate was –0.8% in the male group and –1.2% in the female group. Eventually, in 2014 its values were 721.4 years per 10,000 males and 475.6 years per 10,000 females. The respondents were losing years of life due to ischaemic heart disease (IHD) most rapidly (AAPC = –3.3% in the male group and –3.2% in the female group) and due to cerebrovascular diseases (AAPC = –2.5% in the male group and AAPC = –3.3% in the female group). On the other hand, there was an increase in the number of years of life lost due to heart failure (HF) (AAPC = 5.7% in the male group and AAPC = 4.4% in the female group). In 2014 SEYLLp due to IHD were 207.3 per 10,000 males and 99.1 per 10,000 females, due to cerebrovascular diseases — 124.3 and 102.2, and due to HF — 155.3 and 104.9. Each male who died of CVD lost on average 19.1 years in the year 2000 and 17.0 years in the year 2014 (AAPC = –0.5%). Regarding women, SEYLLd values were 12.6 years in 2000 and 10.4 years in 2014 (AAPC = –1.4%). A decrease in the SEYLLd value was observed in all analysed causes of mortality, in both males and females.

Conclusions: Among CVDs, IHD and cerebrovascular diseases contribute to the highest number of years of life lost in inhabitants of Poland. The constant decline in the average number of years of life lost by each person who died of CVD might result from implementation of more effective prophylaxis and more effective treatment, which extend lifespan.

Get Citation

Keywords

years of life lost, cardiovascular diseases, premature mortality, trends, Poland

About this article
Title

Fifteen-year mortality trends due to cardiovascular diseases in Poland using standard expected years of life lost, 2000–2014

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 75, No 10 (2017)

Pages

1033-1040

Published online

2017-06-28

DOI

10.5603/KP.a2017.0124

Bibliographic record

Kardiol Pol 2017;75(10):1033-1040.

Keywords

years of life lost
cardiovascular diseases
premature mortality
trends
Poland

Authors

Małgorzata Pikala
Irena Maniecka-Bryła

References (27)
  1. Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014; 35(42): 2950–2959.
  2. Penner D, Pinheiro P, Krämer A. Measuring the burden of disease due to premature mortality using Standard Expected Years of Life Lost (SEYLL) in North Rhine-Westphalia, a Federal State of Germany, in 2005. Journal of Public Health. 2010; 18(4): 319–325.
  3. Gènova-Maleras R, Catalá-López F, de Larrea-Baz NF, et al. The burden of premature mortality in Spain using standard expected years of life lost: a population-based study. BMC Public Health. 2011; 11: 787.
  4. Pikala M, Maniecka-Bryla I. Years of life lost due to malignant neoplasms characterized by the highest mortality rate. Arch Med Sci. 2014; 10(5): 999–1006.
  5. Pikala M, Bryla M, Bryla P, et al. Years of Life Lost Due to External Causes of Death in the Lodz Province, Poland. PLoS ONE. 2014; 9(5): e96830.
  6. Plass D, Chau PY, Thach TQ, et al. Quantifying the burden of disease due to premature mortality in Hong Kong using standard expected years of life lost. BMC Public Health. 2013; 13: 863.
  7. Główny Urząd Statystyczny - Dziedzinowa Baza Wiedzy - Demografia. http://swaid.stat.gov.pl/SitePagesDBW/demografia.aspx.
  8. Maniecka-Bryła I, Bryła M, Bryła P, et al. The burden of premature mortality in Poland analysed with the use of standard expected years of life lost. BMC Public Health. 2015; 15: 101.
  9. Wojtyniak B. Choroby układu krążenia jako priorytet zdrowia publicznego; Polska, Europa. In: Strzelecki Z, Szymborski J eds. Zachorowalność i umieralność na choroby układu krążenia a sytuacja demograficzna Polski, Rządowa Rada Ludnościowa, Warszawa. ; 2015: 81–100.
  10. Murray CJL, Lopez A. Globalne Obciążenie Chorobami, tom 1. Uniwersyteckie Wydawnictwo Medyczne „Vesalius, Warszawa 2000.
  11. WHO methods and data sources for global burden of disease estimates 2000-2011. Department of Health Statistics and Information Systems WHO 2013: Geneva.
  12. Marshall RJ. Standard Expected Years of Life Lost as a measure of disease burden: An investigation of its presentation, meaning and interpretation. In: Preedy VR, Watson RR eds. Handbook of disease burdens and quality of life measures, Springer, Berlin 2009: 3421–3434.
  13. Bandosz P, O'Flaherty M, Drygas W, et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ. 2012; 344: d8136.
  14. Prognoza ludności na lata 2014-2050. Główny Urząd Statystyczny, Warszawa. 2014.
  15. Zatonski WA, McMichael AJ, Powles JW. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ. 1998; 316(7137): 1047–1051.
  16. Jasiński B. Udział spadku umieralności z powodu choroby niedokrwiennej serca na spadek umieralności ogólnej w Polsce w latach 1997-2003. Zdrowie Publiczne. 2008; 118: 36–43.
  17. Amiri M, Janssen F, Kunst AE. The decline in ischaemic heart disease mortality in seven European countries: exploration of future trends. J Epidemiol Community Health. 2011; 65(8): 676–681.
  18. Gierlotka M, Zdrojewski T, Wojtyniak B, et al. Incidence, treatment, in-hospital mortality and one-year outcomes of acute myocardial infarction in Poland in 2009-2012--nationwide AMI-PL database. Kardiol Pol. 2015; 73(3): 142–158.
  19. Ryglewicz D. Choroby naczyń mózgowych w Polsce; diagnoza i rekomendacje. In: Strzelecki Z, Szymborski J eds. Zachorowalność i umieralność na choroby układu krążenia a sytuacja demograficzna Polski, Rządowa Rada Ludnościowa, Warszawa. 2015: 203–221.
  20. van Jaarsveld CHM, Ranchor AV, Kempen GI, et al. Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival. Eur J Heart Fail. 2006; 8(1): 23–30.
  21. Maniecka-Bryła I, Pikala M, Bryła M. Life years lost due to cardiovascular diseases. Kardiol Pol. 2013; 71(10): 1065–1072.
  22. Pikala M, Kaleta D, Bielecki W, et al. Awareness of cardiovascular prevention methods among residents of post-communist Polish provinces with highest mortality rates. Cent Eur J Public Health. 2011; 19(4): 183–189.
  23. Pikala M, Burzyńska M, Pikala R, et al. Educational inequalities in premature mortality in Poland, 2002-2011: a population-based cross-sectional study. BMJ Open. 2016; 6(9): e011501.
  24. Pikala M, Burzyńska M, Maniecka-Bryła I. Territorial differences in years of life lost due to premature mortality in inhabitants of Poland. Przegl Epidemiol. 2017; 71(1): 68–79.
  25. Cierniak-Piotrowska M, Marciniak G, Stańczak J. Statystyka zgonów i umieralności z powodu chorób układu krążenia. In: Strzelecki Z, Szymborski J eds. Zachorowalność i umieralność na choroby układu krążenia a sytuacja demograficzna Polski, Rządowa Rada Ludnościowa, Warszawa. 2015: 46–80.
  26. Wojtyniak B, Jankowski K, Zdrojewski T, et al. Regional differences in determining cardiovascular diseases as the cause of death in Poland: time for change. Kardiol Pol. 2012; 70(7): 695–701.
  27. Jankowski P. Czy na pewno wiemy, jakie są przyczyny zgonów w Polsce? Kardiol Pol. 2012; 70: 702.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl